L'institut Domaines de recherche Plates-formes techniques Venir à l'INM. Pourquoi? Actu / presse

U583

Equipe 1
Génétique et thérapie des cécités rétiniennes

Equipe 2
Physiopathologie et thérapies de l’oreille interne

Equipe 3
Neurobiologie cellulaire et moléculaire du système somato-sensoriel

Equipe 4
Physiologie et approches thérapeutiques des pathologies médullaires

Equipe 5
Physiologie et thérapie des désordres vestibulaires

U844

 

| Accueil | Contact | Légal |    

Christian P. Hamel Christian Hamel - responsable Génétique et thérapie des cécités rétiniennes

Function :


MD, PhD, Ophthalmogeneticist, director of the INM and of the team "Genetics and therapy of retinal blindness", and the director of the center of reference for the inherited sensory diseases.

Academic and research track :


C Hamel had his residency in ophthalmology in Caen (France) and spent his post doctoral fellowship (5 years) at the National Institute of Health (USA) in the laboratories of Robert B Nussenblatt and Gerald Chader. Upon return to France, he joined Rémy Pujol’s laboratory in Montpellier (INSERM U254) where he developed research programs on genetics of the retina and on molecular biology of the inner ear. He was appointed as an INSERM Chargé de Recherches and later on became Directeur de Recherches. In the Ophthalmology Department of Montpellier, he raised an outpatient clinic for hereditary diseases of the retina and optic nerve and became the medical coordinator of the Center of Reference for rare diseases “inherited sensory diseases”. In the 2003, he created with Jean-Luc Puel, Jean Valmier, Alain Privat and Jean-Philippe Hugnot, the laboratory entitled “pathophysiology and therapy of sensory and motor defects” (INSERM U583, INM) whose he became the director.

Main achievements :


• During his post doctoral fellowship, he discovered and described the RPE65 protein (M Redmond’s lab) and, back to France, he showed that mutations cause a particular form of Leber congenital amaurosis (Hamel et al., J Biol Chem 1993 ; Marlhens et al., Nature Genetics 1997). He then worked in collaboration with F Rolling on the Briard dog to establish gene therapy for RPE65 patients in Europe (Le Meur et al., Mol Ther 2007).
• More recently, he showed that a mitochondrial dynamin-related protein, OPA1, is responsible for the majority of cases of Kjer disease, one of the leading cause of inherited optic neuropathy (Delettre and Lenaers et al., Nature Genetics, 2000).

Research interests :


• Discovery of the genes causing inherited diseases of the retina and optic nerve, for their extraordinary potential to improve our understanding of the physiology and pathophysiology of vision, and more specifically
o characterize the retinal diseases due to impairment of the visual cycle genes, and how can we modulate the visual cycle to modify the visual function and the natural history of certain diseases
o why are retinal ganglion cells vulnerable to certain mitochondrial defects and how can we act on mitochondrial functions
• Use this knowledge to help patients by providing more accurate informations, better genetic counselling, and by planning strategies of treatment.

Selected publications :

  • Hamel CP, Tsilou E, Pfeffer BA, Hooks JJ, Detrick B, Redmond TM (1993). Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro. J Biol Chem 268, 15751-15757.
  • Marlhens F, Bareil C, Griffoin J-M, Zrenner E, Amalric P, Eliaou C, Liu S-Y, Harris E, Redmond TM, Arnaud B, Claustres M, Hamel CP (1997). Mutations in RPE65 cause Leber’s congenital amaurosis. Nature Genetics 17, 139-141.
  • Delettre C, Lenaers G, Griffoin J-M, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorges J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP (2000). Nuclear gene OPA1 encoding a mitochondrial dynamin-related protein is mutated in dominant optic atrophy. Nature Genetics 26, 207-210.
  • Hamel CP, Griffoin J-M, Laesquellec L, Bazalgette C, Arnaud (2001). Retinal dystrophies caused by mutations in RPE65: assessment of visual functions. Br J Ophthalmol 85, 424-427.
  • Delettre C, Griffoin J-M, Lenaers G, Belenguer P, Hamel CP (2001). Splicing variants and spectrum of mutations in the OPA1 gene. Hum Genet 109, 584-591.
  • Delprat B, Boulanger A, Wang J, Beaudoin V, Guitton MJ, Ventéo S, Dechesne CJ, Pujol R, Lavigne-Rebillard M, Puel J-L, Hamel CP (2002). Downregulation of otospiralin, a novel inner ear protein, causes hair cell degeneration and deafness. J Neurosci 22, 1718-1725.
  • Delprat B, Ruel J, Guitton MJ, Hamard G, Lenoir M, Pujol R, Puel J-L, Brabet P, Hamel CP (2005). Deafness and cochlear fibrocyte alterations in mice deficient for the inner ear protein otospiralin. Mol Cell Biol 25, 847-843.
  • Kamei S, Chen-Kuo-Chang M, Cazevieille C, Lenaers G, Olichon A, Belenguer P, Roussignol G, Renard N, Eybalin M, Micelin A, Delettre C, Brabet P, Hamel CP (2005). Expression of the Opa1 mitochondrial protein in retinal ganglion cells; its down regulation causes aggregation of the mitochondrial network. Invest Ophthalmol Vis Sci 46, 4288-4294.
  • Sénéchal A, Humbert G, Surget M-O, Bazalgette C, Bazalgette C, Arnaud B, Arndt C, Laurent E, Brabet P, Hamel CP (2006). Screening genes of the retinoid metabolism: novel LRAT mutation in Leber congenital amaurosis. Am J Ophthalmol 142, 702-704.

 

Haut de la page

L'institut | Domaines de recherche | Plates-formes techniques |
Venir à l'INM. Pourquoi? | Actu / Presse | Contact |
Accueil | Site map |  Légal & crédits
Directeur de publication: Christian Hamel
Copyright © INM 2006